Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study-Reference-Cited by-同舟云学术

Efficacy and safety of hepatic artery infusion chemotherapy with mFOLFOX in primary liver cancer patients with hyperbilirubinemia and ineffective drainage: a retrospective cohort study

Published:2022-04 Issue:7 Volume:10 Page:411-411
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann Transl Med

Author:

Wang Tianxiao,Dong Jiahong,Zhang Yuewei,Ren Zhizhong,Liu Ying,Yang Xiaowei,Sun Dawei,Wang Yaqin

Publisher

AME Publishing Company

Subject

General Medicine

Link

https://atm.amegroups.com/article/download/92379/pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observation on the effect of sequential psychological intervention combined with body position management in patients with primary liver cancer undergoing hepatic arterial infusion chemotherapy;Journal of Men's Health;2024

2. Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma;Frontiers in Immunology;2023-08-30

3. The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study;Journal of Gastrointestinal Oncology;2023-08

4. Efficacy and safety of CalliSpheres® microspheres drug-eluting beads transarterial chemoembolization in GCLM combined trans-arterial infusion therapy for treating primary focus of gastric cancer: a multi-center retrospective study;Expert Review of Anticancer Therapy;2023-07-28

5. Research trends in cholangiocarcinoma treatments during the last 3 decades;Heliyon;2023-07